Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Homocysteine, vitamin B12 and folate levels in Iranian patients with Multiple Sclerosis: A case control study.
Design and analysis of three-arm trials with negative binomially distributed endpoints.
Balancing Early Aggression Against Risk of Progression in Multiple Sclerosis.
The Treatment experience, burden, and unmet needs (TRIBUNE) study - measuring the socioeconomic consequences of Multiple Sclerosis.
Missed epidemics and missing links: international birth cohort trends in multiple sclerosis.
Updated estimate of AQP4-IgG serostatus and disability outcome in neuromyelitis optica.
Eluding anaphylaxis allows peptide-specific prevention of the relapsing stage of experimental autoimmune encephalomyelitis.
An update on neuro-ophthalmology of multiple sclerosis: the visual system as a model to study multiple sclerosis.
Simvastatin attenuates expression of cytokine-inducible nitric-oxide synthase in embryonic cardiac myoblasts.
Barriers to investigator-initiated deep brain stimulation and device research.
Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis.
Plasma biomarkers discriminate clinical forms of multiple sclerosis.
Improving the clinical correlation of multiple sclerosis black hole volume change by paired-scan analysis.
FTY720 (fingolimod) is a neuroprotective and disease-modifying agent in cellular and mouse models of Huntington disease.
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
MicroRNAs as Active Players in the Pathogenesis of Multiple Sclerosis.
Expansion of CD27(high) plasmablasts in transverse myelitis patients that utilize VH4 and JH6 genes and undergo extensive somatic hypermutation.
Oligoclonal bands in multiple sclerosis reactive against two herpesviruses and association with magnetic resonance imaging findings.
Promoting physical activity to control multiple sclerosis from childhood.
Natalizumab-induced hepatic injury: A case report and review of literature.
Nanotechnology in neurology: Genesis, current status, and future prospects.
Regulation of myelination in the Central Nervous System by Nuclear Lamin B1 and non-coding RNAs.
Progression of multiple sclerosis is associated with gender differences in glutathione S-transferase P1 detoxification pathway.
Cost-effectiveness of fingolimod versus interferon beta-1a for relapsing remitting multiple sclerosis in the United States.
Notable Increased Cerebrospinal Fluid Levels of Soluble Interleukin-6 Receptors in Neuromyelitis Optica.
Pages
« first
‹ previous
…
273
274
275
276
277
278
279
280
281
…
next ›
last »